| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0006 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.05 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | 0.15 | 0.4 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-05 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.2 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | 0.18 | 0.3 |